Chhabra, PreetiTully, Damien C.Mans, JanetNiendorf, SandraBarclay, LeslieCannon, Jennifer L.Montmayeur, Anna M.Pan, Chao-YangPage, Nicola AnneWilliams, RachelTutill, HelenaRoy, SunandoCelma, CristinaBeard, StuartMallory, Michael L.Manouana, Gedeon PrinceVelavan, Thirumalaisamy P.Adegnika, Ayola AkimKremsner, Peter G.Lindesmith, Lisa C.Hue, StephaneBaric, Ralph S.Breuer, JudithVinje, Jan2025-06-112025-06-112024-01Chhabra, P., Tully, D.C., Mans, J. et al. 2024, 'Emergence of novel norovirus GII.4 variant', Emerging Infectious Diseases, vol. 30, no. 1, pp. 163-167, doi : 10.3201/eid3001.231003.1080-6040 (print)1080-6059 (online)10.3201/eid3001.231003http://hdl.handle.net/2263/102751We detected a novel GII.4 variant with an amino acid insertion at the start of epitope A in viral protein 1 of noroviruses from the United States, Gabon, South Africa, and the United Kingdom collected during 2017–2022. Early identification of GII.4 variants is crucial for assessing pandemic potential and informing vaccine development.en© 2024, Centers for Disease Control and Prevention (CDC). All rights reserved.South Africa (SA)United Kingdom (UK)United States (US)Acute gastroenteritisEnteric infectionsNorovirusVirusesEmergence of novel norovirus GII.4 variantArticle